Enter your login e-mail to the account
Search
- HIGH VIROLOGIC SUSTAINED RESPONSE TO FORMER YOUNG INTRAVENOUS DRUG ABUSERS WITH CHRONIC HEPATITIS C TREATED BY PEGYlATED INTERFERON – ALFA PLUS RIBAVIRIN (PRELIMINARY REPORT)
doc. MUDr. František Gazdík, doc. MUDr. Dušan Daniš CSc., RNDr. Kristína Fejdiová, MUDr. Michal Rastislav Piják, MUDr. Alexandra Mesárošová, MUDr. Ľubomír Okruhlica,, MUDr. Karol Laktiš, CSc., MUDr. Igor Stankovič, CSc., doc. MUDr. Katarína Gazdíková, PhD.
(10/2006, From practice ) - FOLLICULAR LYMPHOMA
MUDr. Adriana Kafková
(12/2008, Topic ) - The importance of nutrition in cancer patients
MUDr. Mária Novisedláková
(6/2019, Interdisciplinary consilium )
- Publikujeme v zahraničí
(6/2014, Information & comments ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Hematopoietic stem cell transplantation for multiple myeloma
doc. MUDr. Angelika Bátorová, CSc., doc. MUDr. Martin Mistrík, CSc., MUDr. Eva Bojtárová, MUDr. Ľubica Roziaková, MUDr. Zdenka Štefániková
(3/2013, Focus ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Publikujeme v zahraničí
(3/2014, Information & comments ) - Gastrointestinal malignancies – current position of imunotherapy
MUDr. Dominik Šafčák, PhD., doc. MUDr. Igor Andrašina, CSc.
(1/2023, Main topic ) - Significance of neoadjuvant treatment in patients with early breast cancer – perspective of surgeon
MUDr. Marián Karaba, prof. MUDr. Juraj Benca, PhD., MPH, MUDr. Terézia Lauková, doc. MUDr. Daniel Pinďák, PhD., MUDr. Dominika Rusnáková, MUDr. Martina Vranovská, MUDr. Otília Osifová
(2/2017, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - The current view of the familial adenomatous polyposis (FAP)
MUDr. Vladimír Holec, doc. RNDr. Vladimír Zajac, CSc., Mgr. Zuzana Adamčíková, Ing. Mgr. Katarína Hainová, RNDr. Soňa Čierniková, PhD., Viola Števurková
(2/2012, Review articles ) - The application of biological treatment in metastatic colorectal carcinoma in relation to primary tumor localization
MUDr. Miriam Drahokoupilová, MUDr. Mária Novisedláková, MUDr. Vladimír Václav
(5/2017, Original articles & case reports ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Ruxolitinib for GvHD treatment
MUDr. Barbora Žiaková, MUDr. Eva Bojtárová, PhD., MUDr. Michaela Martišová, PhD., prof. MUDr. Angelika Bátorová, PhD.
(4/2022, Drugs & drug classes ) - The importance of nutrition in cancer patients
MUDr. Mária Novisedláková
(4/2019, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Treatment of myelodysplastic syndrome with high-risk groups
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(4/2014, Spectrum ) - RADIOTHERAPY PROSTATE CANCER
MUDr. Pavol Dubinský, PhD.
(5/2008, Review articles ) - ESMO KONGRES, 12. – 16. 9. 2008, ŠTOKHOLM
MUDr. Marián Streško
(5/2008, Events ) - Ewing sarcoma – our treatment experiences
MUDr. Vanda Mikudová, MUDr. Andrej Jurík, MUDr. Michaela Kubíčková, MUDr. Tomáš Minárik, PhD., MUDr. Silvia Cingelová, PhD., MUDr. Jozef Šufliarsky, PhD., MUDr. Michaela Sojáková, PhD.
(1/2019, Main topic ) - ESMO KONGRES, ŠTOKHOLM, 12. – 16. 9. 2008, FIRST SLOVAKIAN EXPERIENCE
MUDr. Tomáš Šálek a kol.
(5/2008, Events ) - Cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma
MUDr. Radovan Barila, PhD.
(3/2021, Drugs & drug classes ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - The Intention of 18FDG-PET in Childhood and Adolescent Malignant Lymphoma
MUDr. Judita Puškáčová, doc. MUDr. Izabela Makaiová , CSc.
(2/2009, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - Publikujeme v zahraničí
(1/2015, Information & comments ) - Gravidita po onkologickej liečbe
MUDr. Katarína Rejleková, PhD.
(3/2018, Review articles ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - THE INTRODUCTION TO INTERPRETATION OF CLINICAL TRIALS – Part II.
MUDr. Michal Mego, PhD., MUDr. Mária Rečková
(3/2008, Review articles ) - Panobinostat in treatment of multiple myeloma
MUDr. Miriam Ladická
(6/2017, Drugs & drug classes ) - Surgical treatment of pancreas carcinoma
prof. MUDr. Juraj Pechan, CSc., MUDr. Róbert Duchoň, doc. MUDr. Daniel Pinďák, PhD., MUDr. Róbert Šucha, MUDr. Jozef Dolník
(3/2012, Main topic ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Prognostic indicators and significance of response in multiple myeloma
MUDr. Ľudmila Demitrovičová, MUDr. Eva Mikušková, MUDr. Lucia Copáková
(2/2013, Focus ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - ABC transporters: multidrug resistance and different types of human diseases
prof. MUDr. Stanislav Špánik, CSc., doc. MUDr. Viera Lehotská, PhD., MUDr. Katarína Rauová, RNDr. Eva Weismanová, PhD., RNDr. Ľubomír Horváth, CSc., Mgr. Ján Markus, PhD., MUDr. Ladislav Sopko
(1/2012, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA – STAGING AND TREATMENT (PART 2)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(6/2008, Review articles ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - MELANOMA FÓRUM
MUDr. Tomáš Šálek
(6/2008, Events ) - Chemotherapy in combination with radiotherapy in locally advanced head and neck carcinoma
doc. MUDr. Pavol Dubinský, PhD.
(2/2015, Review articles ) - Nonseminomatous testicular tumors
doc. MUDr. Michal Mego, PhD., MUDr. Michal Chovanec
(6/2012, Main topic ) - COVID-19 and patients with hematological malignancies
doc. MUDr. Ľuboš Drgoňa, CSc.
(3/2022, Main topic ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - INTERNATIONAL MEETING ON INNOVATIVE APPROACHES IN HEAD AND NECK ONCOLOGY,BARCELONA 2007
MUDr. Tibor Barta, PhD.
(3/2007, Events ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles )
- Výber abstraktov zo XIV. kongresu slovenských a českých dermatovenerológov s medzinárodnou účasťou, Jasná 2018
redakcia
(3/2018, Abstracts ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year )
- Current approach to the diagnostics and treatment of acute colonic diverticulitis
MUDr. Róbert Kilík, PhD., Ing. MUDr. Otto Brandebur, MUDr. Rastislav Kalanin, PhD., MUDr. Peter Zavacký, prof. MUDr. Jozef Radoňak, CSc., MPH
(4/2015, Review articles )
- Predictors of hospital mortality in intensive care unit patients in teaching hospitals in Trnava in period 2009-2011
RNDr. Jaroslava Sokolová, PhD., Mgr. Zuzana Škvarková, MUDr. Jarmila Železkovová, MBA, MUDr. Alexandra Šimková PhD.
(1/2012, Original articles )